Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1994 1
1998 1
2000 1
2008 1
2009 2
2010 1
2012 1
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Unresectable Thyroid Gland Follicular Carcinoma"
Page 1
Histological findings of thyroid cancer after lenvatinib therapy.
Okubo Y, Toda S, Sato S, Yoshioka E, Ono K, Hasegawa C, Washimi K, Yokose T, Miyagi Y, Iwasaki H, Hayashi H. Okubo Y, et al. Histopathology. 2023 Oct;83(4):657-663. doi: 10.1111/his.15013. Epub 2023 Jul 28. Histopathology. 2023. PMID: 37501641
AIMS: Lenvatinib is a multikinase inhibitor used for treating unresectable or metastatic cancers, including thyroid cancer. As total thyroidectomy followed by radioactive iodine therapy is a commonly recommended initial treatment for thyroid cancer, histologi …
AIMS: Lenvatinib is a multikinase inhibitor used for treating unresectable or metastatic cancers, including thyroid cancer. As …
Radioiodine and radiotherapy in the management of thyroid cancers.
Simpson WJ. Simpson WJ. Otolaryngol Clin North Am. 1990 Jun;23(3):509-21. Otolaryngol Clin North Am. 1990. PMID: 1694984 Review.
Radioiodine is an important adjuvant treatment in the management of resectable papillary and follicular thyroid cancers in all patients except those with the best prognostic features. ...In all types of thyroid cancer, external radiotherapy may produce benefi …
Radioiodine is an important adjuvant treatment in the management of resectable papillary and follicular thyroid cancers in all …
The impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland.
Nixon IJ, Whitcher MM, Palmer FL, Tuttle RM, Shaha AR, Shah JP, Patel SG, Ganly I. Nixon IJ, et al. Thyroid. 2012 Sep;22(9):884-9. doi: 10.1089/thy.2011.0535. Epub 2012 Jul 24. Thyroid. 2012. PMID: 22827579 Free PMC article.
METHODS: Fifty-two patients with distant metastases from thyroid cancer diagnosed before thyroid surgery (n=32) or on a postoperative RAI scan after thyroid surgery (n=20) were identified from a database of patients with WDTC treated between 1985 and 2005. .. …
METHODS: Fifty-two patients with distant metastases from thyroid cancer diagnosed before thyroid surgery (n=32) or on a postop …
The clinical course of poorly differentiated thyroid carcinoma (insular carcinoma) - own observations.
Walczyk A, Kowalska A, Sygut J. Walczyk A, et al. Endokrynol Pol. 2010 Sep-Oct;61(5):467-73. Endokrynol Pol. 2010. PMID: 21049460
INTRODUCTION: Poorly differentiated thyroid carcinoma (PDTC, insular carcinoma) occurs rarely. It is described with more aggressive behaviour, poorer prognosis, and higher mortality than well differentiated thyroid carcinoma (WDTC). ...The medic …
INTRODUCTION: Poorly differentiated thyroid carcinoma (PDTC, insular carcinoma) occurs rarely. It is described with mor …
Embolization in combination with radioiodine therapy for bone metastases from differentiated thyroid carcinoma.
Van Tol KM, Hew JM, Jager PL, Vermey A, Dullaart RP, Links TP. Van Tol KM, et al. Clin Endocrinol (Oxf). 2000 May;52(5):653-9. doi: 10.1046/j.1365-2265.2000.00998.x. Clin Endocrinol (Oxf). 2000. PMID: 10792347
BACKGROUND: The outcome for patients with bone metastases from differentiated thyroid carcinoma is worse compared to the overall prognosis of patients with differentiated thyroid carcinoma. The aim of this study is to evaluate the effect of embolizatio …
BACKGROUND: The outcome for patients with bone metastases from differentiated thyroid carcinoma is worse compared to the overa …
Unresectable huge sternal and mediastinal metastasis of follicular thyroid carcinoma; radiotherapy as first-line and palliative therapy.
Nar Demirer A, Ayturk S, Tutuncu NB, Gursoy A, Pak Y, Demirag NG. Nar Demirer A, et al. Exp Clin Endocrinol Diabetes. 2009 Apr;117(4):155-8. doi: 10.1055/s-2008-1078743. Epub 2008 Jun 17. Exp Clin Endocrinol Diabetes. 2009. PMID: 18561094
Distant metastases as initial manifestation of follicular thyroid carcinoma is rare. We report a case of an unusual initial presentation of follicular thyroid carcinoma on follow-up. ...Multiple lymph nodes were observed in the supraclavi …
Distant metastases as initial manifestation of follicular thyroid carcinoma is rare. We report a case of an unusual ini …
Results of rosiglitazone therapy in patients with thyroglobulin-positive and radioiodine-negative advanced differentiated thyroid cancer.
Kebebew E, Lindsay S, Clark OH, Woeber KA, Hawkins R, Greenspan FS. Kebebew E, et al. Thyroid. 2009 Sep;19(9):953-6. doi: 10.1089/thy.2008.0371. Thyroid. 2009. PMID: 19678746
BACKGROUND: Rosiglitazone is a peroxisome proliferator-activated receptor (PPAR) gamma agonist that has shown promise as both an antiproliferative and redifferentiating agent for the treatment of thyroid cancer in preclinical studies. We investigated the efficacy and side …
BACKGROUND: Rosiglitazone is a peroxisome proliferator-activated receptor (PPAR) gamma agonist that has shown promise as both an antiprolife …
Use of radioactive iodine for thyroid remnant ablation in well-differentiated thyroid carcinoma to replace thyroid reoperation.
Lin JD, Chao TC, Huang MJ, Weng HF, Tzen KY. Lin JD, et al. Am J Clin Oncol. 1998 Feb;21(1):77-81. doi: 10.1097/00000421-199802000-00018. Am J Clin Oncol. 1998. PMID: 9499265
From January 1977 to December 1995, 210 papillary or follicular thyroid carcinoma patients received subtotal thyroidectomy or lobectomy. ...Misinterpretation of follicular cancer as benign lesions and unresectable tumor comprised the main reason …
From January 1977 to December 1995, 210 papillary or follicular thyroid carcinoma patients received subtotal thyroidect …
Outcomes of repeat fineneedle aspiration biopsy for AUS/FLUS thyroid nodules.
Bayona A, Benavent P, Muriel A, Abuchaibe C, Sharpe SC, Tarasova V, McIver B, Valderrabano P. Bayona A, et al. Eur J Endocrinol. 2021 Aug 27;185(4):497-506. doi: 10.1530/EJE-21-0330. Eur J Endocrinol. 2021. PMID: 34313606
Two investigators extracted summary data and assessed the risk of bias. Data were pooled using a random-effects model. The rate of malignancy was calculated on resected nodules only (upper limit of true value); and considering all unresected nodules were benign (low …
Two investigators extracted summary data and assessed the risk of bias. Data were pooled using a random-effects model. The rate of ma …
Thyroidectomy in patients with marked thyroid enlargement: airway management, morbidity, and outcome.
McHenry CR, Piotrowski JJ. McHenry CR, et al. Am Surg. 1994 Aug;60(8):586-91. Am Surg. 1994. PMID: 8030813
Six (21%) of 29 patients had temporary hypocalcemia compared to eight (13%) of 62 patients with lesser thyroid enlargement (P = 0.36). One patient with an unresectable follicular carcinoma died from aspiration pneumonia three weeks following tracheosto …
Six (21%) of 29 patients had temporary hypocalcemia compared to eight (13%) of 62 patients with lesser thyroid enlargement (P = 0.36) …